Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

By Title L.M.   Giddens K.   McInerney M.M.   McQueen M.J.   Nassar B.A.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1747-1753

Elsevier

Access to resources Recommend Favorite

The Molecular Markers of Hemostatic Activation on Coronary Artery Disease

By Ulutin T.   Sonmez H.   Ucisik N.   Suer S.   Bayram C.   Kokoglu E.   Sultuybek G.  

Thrombosis Research, Vol. 88, Iss. 3, 1997-11 ,pp. : 329-332

Elsevier

Access to resources Recommend Favorite

Effects of raloxifene on endothelial-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease

By Griffiths K.A.   Sader M.A.   Skilton M.R.   Harmer J.A.   Celermajer D.S.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 25-26

Elsevier

Access to resources Recommend Favorite

PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease

By Azarsiz E.   Kayikcioglu M.   Payzin S.   Yildirim Sozmen E.  

International Journal of Cardiology, Vol. 91, Iss. 1, 2003-09 ,pp. : 43-51

Elsevier

Access to resources Recommend Favorite

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA 1/2 polymorphism

By Kranzhofer Roger   Ruef Johannes  

Platelets, Vol. 17, Iss. 3, 2006-05 ,pp. : 163-169

Informa Healthcare

Access to resources Recommend Favorite